Inventor · disambiguated record
Mark Andres
Also filed as: ANDRES MARK · ANDRES MARK C · ANDRES MARK CHRISTOPHER
24 granted patents·13 pending applications·78 citations·filing 2006–2025
95Inventor score
Files withDERMIRA INC6NEURMEDIX INC6ARTELO BIOSCIENCES INC4JOURNEY MEDICAL CORP4GILEAD SCIENCES INC3
Top patents by PatentIndex Score
37 records- 0195US9259414B2Glycopyrrolate saltsDERMIRA INC·Filed 2015·Granted Feb 16, 2016·8 cites·21 claims
- 0295US9006462B2Glycopyrrolate saltsDERMIRA INC·Filed 2014·Granted Apr 14, 2015·13 cites·24 claims
- 0391US11807627B2Morphic forms of complement factor D inhibitorsACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 7, 2023·5 cites·20 claims
- 0489US9643956B2Solid forms of an ASK1 inhibitorGILEAD SCIENCES INC·Filed 2015·Granted May 9, 2017·9 cites·81 claims
- 0587US10004717B2Glycopyrrolate saltsDERMIRA INC·Filed 2017·Granted Jun 26, 2018·5 cites·31 claims
- 0687US9850271B2Crystalline solvate forms of a pharmaceuticalNEURMEDIX INC·Filed 2016·Granted Dec 26, 2017·4 cites·20 claims
- 0787US8252947B2Solid state forms of a pharmaceuticalWHITE STEVEN K·Filed 2009·Granted Aug 28, 2012·8 cites·6 claims
- 0886US9610278B2Glycopyrrolate saltsDERMIRA INC·Filed 2016·Granted Apr 4, 2017·4 cites·33 claims
- 0985US9555046B2Crystalline anhydrate forms of a pharmaceuticalNEURMEDIX INC·Filed 2014·Granted Jan 31, 2017·5 cites·8 claims
- 1084US10604467B2Solid forms of cannabidiol and uses thereofARTELO BIOSCIENCES INC·Filed 2019·Granted Mar 31, 2020·2 cites·9 claims
- 1184US8410127B2Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine saltsSONG JIANGAO·Filed 2010·Granted Apr 2, 2013·9 cites·12 claims
- 1280US10946004B2Solid forms of an ASK1 inhibitorGILEAD SCIENCES INC·Filed 2019·Granted Mar 16, 2021·2 cites·8 claims
- 1379US10995112B2Crystalline solvate forms of a pharmaceuticalNEURMEDIX INC·Filed 2019·Granted May 4, 2021·0 cites·8 claims
- 1479US9877972B2Treatment methods using pharmaceutical solid state formsNEURMEDIX INC·Filed 2014·Granted Jan 30, 2018·2 cites·22 claims
- 1578US10548875B2Glycopyrrolate saltsDERMIRA INC·Filed 2018·Granted Feb 4, 2020·1 cites·27 claims
- 1677US10543192B2Glycopyrrolate saltsDERMIRA INC·Filed 2018·Granted Jan 28, 2020·1 cites·41 claims
- 1776US2025186395A1Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2025·Application pending·0 cites
- 1875US2022002338A1Crystalline solvate forms of a pharmaceuticalNEURMEDIX INC·Filed 2021·Application pending·0 cites
- 1972US11291652B2Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2020·Granted Apr 5, 2022·0 cites·17 claims
- 2072US11291651B2Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2020·Granted Apr 5, 2022·0 cites·23 claims
- 2170US2023404939A1Solid forms of cannabidiol and uses thereofARTELO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2267US2019177258A1New solid forms of cannabidiol and uses thereofARTELO BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2364US11364202B2Solid forms of cannabidiol and uses thereofARTELO BIOSCIENCES INC·Filed 2020·Granted Jun 21, 2022·0 cites·14 claims
- 2464US2018208623A1Crystalline solvate forms of a pharmaceuticalNEURMEDIX INC·Filed 2017·Application pending·0 cites
- 2561US9150567B2Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine saltsCYMABAY THERAPEUTICS INC·Filed 2014·Granted Oct 6, 2015·0 cites·5 claims
- 2659US2012302537A1Treatment methods using pharmaceutical solid state formsWHITE STEVEN K·Filed 2012·Application pending·0 cites
- 2759US2012296105A1Crystalline anhydrate forms of a pharmaceuticalWHITE STEVEN K·Filed 2012·Application pending·0 cites
- 2858US2022233500A1Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2022·Application pending·0 cites
- 2956US2018243281A1Solid forms of an ask1 inhibitorGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3055US8815886B2Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine saltsSONG JIANGAO·Filed 2013·Granted Aug 26, 2014·0 cites·20 claims
- 3153US2010286400A1Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazoleTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 3250US8324383B2Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrileANDRES MARK·Filed 2009·Granted Dec 4, 2012·0 cites·1 claims
- 3349US8389778B2Preparation of mannitol modification IIIHENCK JAN-OLAV·Filed 2008·Granted Mar 5, 2013·0 cites·18 claims
- 3449US2022160713A1Selective inhibitor of protein arginine methyltransferase 5 (prmt5)PRELUDE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3539US2008070961A1Polymorphs of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamideREICHWEIN JOHN F·Filed 2007·Application pending·0 cites
- 3637US2007066635A1Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use thereforANDRES MARK·Filed 2006·Application pending·0 cites
- 3730US8524782B2Key intermediate for the preparation of Stilbenes, solid forms of Pterostilbene, and methods for making the sameSUBBARAJU GOTTUMUKKALA V·Filed 2011·Granted Sep 3, 2013·0 cites·39 claims
Join the waitlist — get patent alerts
Get an alert when Mark Andres files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →